TrialJAMA network open2022

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.

Connie N Hess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.